Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 15 matching records.
15 results — page 1 of 1
- Level AMeta-analysisEurope PMC
Therapeutic potential of mesenchymal stem cell-derived extracellular vesicle in nonalcoholic fatty liver disease: a systematic review and meta-analysis of preclinical evidence
Meta-analysis, published in Lipids Health Dis (2025) — summary generated from the PubMed abstract.
- 2025
Lipids Health Dis3 citations - Level DAnimal StudyEurope PMC
Adipose-targeted SWELL1 deletion exacerbates obesity- and age-related nonalcoholic fatty liver disease
Animal Study on Type 2 Diabetes, published in JCI Insight (2023) — summary generated from the PubMed abstract.
- 2023
JCI Insight10 citations - Level DNarrative ReviewEurope PMC
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease
Narrative Review on Type 2 Diabetes, Immune Modulation, published in Rev Endocr Metab Disord (2023) — summary generated from the PubMed abstract.
- 2023
Rev Endocr Metab Disord38 citations - Level DNarrative ReviewEurope PMC
Role of extracellular vesicles in nonalcoholic fatty liver disease
Narrative Review on Type 2 Diabetes, published in Front Endocrinol (Lausanne) (2023) — summary generated from the PubMed abstract.
- 2023
Front Endocrinol (Lausanne)12 citations - Level CProspective StudyEurope PMC
Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice
Prospective Study with a reported sample of 214, published in J Biol Chem (2022) — summary generated from the PubMed abstract.
- 2022
- n = 214
J Biol Chem14 citations - Level CProspective StudyPubMed
Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
Prospective Study on Type 2 Diabetes, published in Gastroenterology (2021) — summary generated from the PubMed abstract.
- 2021
Gastroenterology144 citations - Level DNarrative ReviewEurope PMC
Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus
Narrative Review on Type 2 Diabetes, published in J Diabetes Res (2021) — summary generated from the PubMed abstract.
- 2021
J Diabetes Res - Level DAnimal StudyPubMed
Characterization of adipose tissue-derived stromal cells of mice with nonalcoholic fatty liver disease and their use for liver repair.
Animal Study on Face & Skin, published in Regen Ther (2021) — summary generated from the PubMed abstract.
- 2021
Regen Ther7 citations - Level DAnimal StudyPubMed
A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo.
Animal Study, published in Diabetes (2020) — summary generated from the PubMed abstract.
- 2020
Diabetes - Level DNarrative ReviewPubMed
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
Narrative Review, published in Transplantation (2019) — summary generated from the PubMed abstract.
- 2019
Transplantation - Level DAnimal StudyEurope PMC
Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease
Animal Study on Type 2 Diabetes, published in Sci Rep (2019) — summary generated from the PubMed abstract.
- 2019
Sci Rep27 citations - Level DAnimal StudyEurope PMC
Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease
Animal Study on Type 2 Diabetes, published in Cell Death Dis (2016) — summary generated from the PubMed abstract.
- 2016
Cell Death Dis39 citations - Level CProspective StudyEurope PMC
Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with Nonalcoholic Fatty Liver Disease
Prospective Study on Type 2 Diabetes, published in PLoS One (2014) — summary generated from the PubMed abstract.
- 2014
PLoS One38 citations - Level DAnimal StudyEurope PMC
TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice
Animal Study on Type 2 Diabetes, published in Diabetes (2012) — summary generated from the PubMed abstract.
- 2012
Diabetes69 citations - Level DLaboratory StudyEurope PMC
Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease
Laboratory Study, published in ISRN Gastroenterol (2011) — summary generated from the PubMed abstract.
- 2011
ISRN Gastroenterol91 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406